Back to articles
Comparative guide · 6 min read

Spermidine vs Resveratrol — two longevity bets that haven't paid off

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

Both have impressive yeast, worm, fly, and mouse data. Both have human trial bases that are smaller, shorter, and less impressive than the marketing implies. Resveratrol is the older bet — fifteen-plus years of human studies that have largely disappointed on the cardio-metabolic and longevity endpoints originally promised. Spermidine is the newer bet, with autophagy-induction as its mechanistic story and a small but growing trial base. Both belong in the "interesting science, weak human translation" category — and both are sold as if they were Tier 1 anti-aging compounds.

Quick verdict

GoalBetter choiceWhy
Demonstrated longevity / lifespan effect in humans Neither No supplement has demonstrated lifespan extension in humans. Both have only observational/preclinical signals.
Cardiometabolic improvement (lipids, glucose, BP) Resveratrol (modest) Some trials show small effects on inflammatory markers and modest BP/glycaemia signals; larger RCTs have been disappointing.
Cognitive aging / memory Spermidine (very modestly) The Schwarz 2018 SmartAge pilot suggested cognitive benefit in older adults at risk of dementia; replication is needed.
Inflammatory markers (CRP, IL-6) Resveratrol (small) Meta-analyses show modest CRP reduction; clinical relevance unclear.
Hair growth / skin aging Both have weak signals Topical resveratrol has small skin signals; spermidine's hair-growth data is preliminary.
"I want to feel younger / live longer" Sleep, exercise, weight, social connection The actual longevity literature in humans is much more about lifestyle than supplements.

How they compare on the things that matter

Mechanism — sirtuins vs autophagy, both contested

Resveratrol's original story was sirtuin activation — particularly SIRT1 — which would mimic some of the effects of caloric restriction in extending healthy lifespan. The mechanism has held up poorly under scrutiny: subsequent work suggests resveratrol's effects on SIRT1 in early studies may have been an artefact of the fluorescent assay used. The compound has real biological effects (anti-inflammatory, modest insulin-sensitising in some preparations), just not via the cleanest sirtuin story.

Spermidine's story is autophagy induction — promoting the cellular self-cleanup process that degrades damaged proteins and organelles, which has solid mechanistic support as a longevity-relevant pathway. The mechanism of oral spermidine in humans is less clear because spermidine is also produced endogenously and by the gut microbiome; whether oral supplementation meaningfully changes systemic spermidine status above what the gut microbiome already provides is contested.

Evidence base by clinical endpoint

Practical rule. Neither belongs in a "core" supplement stack on the basis of human evidence. If you're already optimising the things that matter (cardiovascular fitness, sleep, body composition, social connection, not smoking, modest alcohol or none) and have an experimental budget for low-evidence "longevity adjuncts," spermidine has the slightly more interesting current trajectory in cognitive aging trials. But it's still an experiment, not an established intervention.

Dose and form

For resveratrol, doses in trials have ranged from 75 mg to 5 g/day, with the higher-dose trials showing more side effects without proportional benefit. Trans-resveratrol is the active stereoisomer; cis-resveratrol is largely inactive. Bioavailability is poor (~1–2%); some preparations claim improved absorption (micronised, with piperine, liposomal) but no clear winner emerges from comparative trials. If used: 250–500 mg/day of trans-resveratrol with a fatty meal.

For spermidine, trial-cited doses range from 1.2 mg/day (wheat germ extract preparations like Spermidine Life) to higher pharmacological doses. The food-equivalent comparison: a heavy serving of natto, aged cheese, mushrooms, or wheat germ provides similar amounts to most supplements. If used: 1–6 mg/day from a wheat germ extract preparation.

Safety

Resveratrol is generally well-tolerated. GI upset is the most common adverse effect, dose-dependent. Higher doses (above 2.5 g/day) can cause renal dysfunction in susceptible users. Inhibits some CYP3A4-metabolised drugs at high doses; discuss with prescriber if on chronic medications. Theoretical additive antiplatelet effect — caution in users on anticoagulants.

Spermidine is generally well-tolerated. Long-term safety at supplemental doses is not extensively characterised. Theoretical concerns about polyamines and tumour growth have not translated to safety signals in human trials, but caution in active malignancy and during conventional cancer treatment is reasonable.

What the price difference buys you

Resveratrol runs $0.30–0.80/day at trial-cited doses. Spermidine wheat-germ extract runs $0.80–1.50/day. The "longevity stack" combination products that bundle both with NMN, NR, fisetin, and various honourable mentions typically run $80–200/month — almost always poor value relative to running a single ingredient at a trial-cited dose, if you're going to use any of them.

Who should skip each

Resveratrol should be approached cautiously in pregnancy and lactation (limited data), in users on anticoagulants, in users on CYP3A4-metabolised medications at higher resveratrol doses, and in anyone with hormone-sensitive cancer history (resveratrol has phytoestrogenic activity at higher exposures).

Spermidine should be approached cautiously in active malignancy and during conventional cancer treatment due to the theoretical role of polyamines in tumour proliferation. Pregnancy and lactation safety data are insufficient.

What we'd actually buy

For "I want to invest in healthspan and have a budget for evidence-based interventions": prioritise zone 2 cardio, resistance training 2–3× per week, sleep duration of 7+ hours, blood pressure control, and not smoking — the longevity literature in humans is overwhelmingly behavioural, not pharmacological.

For supplement stacks that have meaningful human data in older adults: vitamin D3 to a 30–50 ng/mL 25-OH-D target, omega-3 EPA/DHA at 1–2 g/day combined, creatine monohydrate 5 g/day, and dietary protein at 1.2–1.6 g/kg/day. These have larger and more consistent effects than either spermidine or resveratrol.

For experimental adjuncts in users who insist: spermidine 1–3 mg/day from a wheat-germ extract preparation has the slightly more interesting current trajectory. Resveratrol's trial trajectory has been mostly disappointing for fifteen years and we'd skip it.

Sources

Read more: